Navigation Links
Perrigo Reports Record Revenue and Adjusted Earnings
Date:5/7/2013

ortion of long-term debt

41,28540,00040,000Total current liabilities

673,620652,731629,751Non-current liabilitiesLong-term debt, less current portion

1,331,6841,329,2351,454,620Non-current deferred income taxes

80,47424,12619,543Other non-current liabilities

184,782165,310163,466Total non-current liabilities

1,596,9401,518,6711,637,629Shareholders' EquityControlling interest:Preferred stock, without par value, 10,000 shares authorized

———Common stock, without par value, 200,000 shares authorized

530,780504,708496,320Accumulated other comprehensive income

87,27339,40475,800Retained earnings

1,605,8941,306,9251,198,7402,223,9471,851,0371,770,860Noncontrolling interest

1,3811,6081,814Total shareholders' equity

2,225,3281,852,6451,772,674$
4,495,888$
4,024,047$
4,040,054Supplemental Disclosures of Balance Sheet InformationAllowance for doubtful accounts

$
2,219$
2,556$
2,483Working capital

$
,024,008$
,143,190$
,161,137Preferred stock, shares issued and outstanding

———Common stock, shares issued and outstanding

94,02293,48493,405 PERRIGO COMPANYCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands)(unaudited)Nine Months EndedMarch 30, 2013March 31, 2012Cash Flows From (For) Operating ActivitiesNet income$
323,459$
285,924Adjustments to derive cash flowsGain on sale of pipeline development projects—(3,500)Restructuring—7,081Losses on sales of investments4,657—Depreciation and amortization112,817101,712Share-based compensation14,03713,924Income tax benefit from exercise of stock options(271)(447)Excess tax benefit of stock transactions(15,365)(12,202)Deferred income taxes(3,069)12,021Subtotal436,265404,513Changes in operating assets and liabilities, net of business acquisitionsAccounts receivable(5,919)(28,723)Inventories(81,269)(27,
'/>"/>

SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013
2. Perrigo Company To Present At The Barclays Global Healthcare Conference
3. Perrigo Company To Present At The RBC Global Healthcare Conference
4. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
5. Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
6. Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million
7. Perrigo Confirms FDA Approval For Testosterone Gel 1%
8. Perrigo Reports Record Second Quarter Revenue, Adjusted Earnings and Operating Cash Flow
9. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
10. Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05%
11. Perrigo Company To Release Second Quarter Fiscal Year 2013 Results On February 1, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015 Valencia Technologies Corporation ... patient with its radically small device for the ... early results in this randomized, double-blinded, controlled trial are ... of confidence that it will succeed in a large ... early clinical results, Valencia has ...
(Date:3/2/2015)... 2015 Following announcements from both Novartis ... BioPharma Inc. (NASDAQ:  ARRY) today announced the completion ... with Novartis.  Along with global ownership of both ... $85 million from Novartis. Ron Squarer, ... of the Novartis-GSK transaction, Array now owns both ...
(Date:3/2/2015)... , March 2, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a once-daily, ... cholesterol gallstones, today announced that Josh Blacher , ... the 27th Annual ROTH conference in Laguna ... at 2:30 PM Pacific Standard Time. A live webcast ...
Breaking Medicine Technology:Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Galmed Pharmaceuticals to Present at the 27th Annual ROTH Conference 2
... , SAN ... marketer of the VerifyNow® System, the first rapid and easy-to-use ... agents (e.g. Plavix® and aspirin), announced today that Timothy I. ... Chief Financial Officer of Accumetrics, will be presenting a corporate ...
... , RALEIGH, N.C., Nov. 24 ... for the pharmaceutical and biotech industry, today announced the launch ... The new Hospital Marketplace e-course is the newest ... a comprehensive series of e-courses designed to fill the critical ...
Cached Medicine Technology:Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 3
(Date:3/2/2015)... California (PRWEB) March 02, 2015 Final ... of the TranStatic Volume 2 from Pixel Film Studios. , ... made exclusively for FCPX,” said Christina Austin, CEO of Pixel ... have in any Final Cut Pro X editors toolbox.” , ... to the next with media altering static scrambling effects from ...
(Date:3/1/2015)... Women’s Excellence is pleased to announce ... on their website. There are over 75 terms and phrases ... , “This gives our patients a better understanding of what ... they may not understand. With this resource, our patients are ... and find terms and phrases that they may not remember or ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
(Date:3/1/2015)... “ The Barrel Mill ” was featured ... takes a look at the latest and coolest technology products ... NewsWatch and a technology expert, conducted the review and shared ... drinks. , According to Home Distillation of Alcohol, it's understood ... there’s a pretty cool product that’ll help anyone achieve a ...
(Date:2/28/2015)... Heart diseases are on the rise in India. ... population and 5 percent of rural adult population suffer ... of them require specialized investigation and treatment to prevent ... (CVD). , A division of Indian Business News Agency ... “Indian Coronary Stent Market Forecast to 2019”. The new ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3
... ... weight loss can be with HCG Diet Drops , ... (PRWEB) June 14, 2010 -- It is no secret that obesity has reached epidemic ... suffering from health problems as a result of the extra pounds. , , ,But thanks ...
... CerMedia ... the Cell-Pore product group previously owned and operated by NanoDynamics, Inc. ... Buffalo, NY (PRWEB) ... of the principal manufacturing and production assets, inventory and certain information of the Cell-Pore ...
... ... specialist in cosmetic, facial plastic, and reconstructive surgery, understands that women need options. With ... patients an alternative method to breast implant surgery. Natural breast augmentation allows patients the ... ...
... N.C. Monday, June 14, 2010 A new study ... shows that millions of cancer survivors are forgoing needed medical ... today in CANCER, a peer-reviewed journal of the ... long-term health and well-being of cancer survivors could suffer because ...
... ... medical and financial benefits. The Sit&SipTM bottle is engineered for easy and healthy performance. ... ... 15 - 20 million visits to the doctor each year in the U.S. Acute ...
... ... , ... The Primax Electronic Cigarette System is now available from Primevapor.com., , ,Primevapor has combined a ... These cartridges not only produce more flavor and more vapor, but use US manufactured, vegetable ...
Cached Medicine News:Health News:Thousands Drop The Weight For Good with HCG Diet Drops 2Health News:CerMedia Completes Purchase of Cell-Pore Principal Assets from NanoDynamics 2Health News:Del Mar Plastic Surgeon Dr. Maurice Sherman Now Offering Natural Breast Implant Alternatives 2Health News:Cost concerns prevent many cancer survivors from getting medical care 2Health News:Ear Infection is the Most Common Reason Why an American Child Sees the Doctor 2Health News:Ear Infection is the Most Common Reason Why an American Child Sees the Doctor 3Health News:Electronic Cigarettes Are Better Than Ever 2
The VPAP III is a complete system solution for sleep-disordered breathing (SDB), providing comfortable and effective bilevel treatment. The VPAP III is an effective business solution for clinicians, ...
... for the Separation and Measurement of ... Subfractions, ,The Lipoprint System is a ... components which are not routinely tested ... provides detailed results within the subfractions ...
... high resolution diagnostic test for cholesterol components which ... test procedure is simple and can be done ... is clearly flagged. A color coded profile is ... in red and the good HDL in green. ...
... Ammonia/Alcohol Control is intended as ... ammonia and ethanol assay methods. ... targeted at clinically significant levels ... values are provided for the ...
Medicine Products: